Finding SUbcliNical atRial fIbrillation in Stroke patiEnts
- Conditions
- atrial fibrillationcardiac arrhythmia1000752110007963
- Registration Number
- NL-OMON56866
- Lead Sponsor
- Radboud Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 600
Inclusion Criteria
• Patients with the diagnosis of ischaemic stroke with neuroimaging
confirmation of cer-ebral ischemia (tissue-based definition), either with CT or
MRI
• Age 18 years or older, both male and female
• Written consent by patients or legal representative
• Diagnosis with and without atrial fibrillation
Exclusion Criteria
• Unable or unwilling to participate or consent
• For the MRI-substudy: Unwillingness to undergo MRI, or contra-indication for
MRI
• Pregnancy
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>occurrence of (subclinical) AF.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Risk factors for AF<br /><br>Cognitive deficits<br /><br>Depression, fatigue, return to work and quality of life</p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link subclinical atrial fibrillation to increased stroke risk in SUNRISE trial patients?
How does non-invasive AF detection in SUNRISE compare to standard ECG monitoring for post-stroke cardiac arrhythmia screening?
Which biomarkers are associated with subclinical atrial fibrillation detection in 600 stroke patients from SUNRISE?
What adverse events are reported in stroke patients with undiagnosed atrial fibrillation using non-invasive monitoring?
How do anticoagulant therapies like NOACs impact stroke recurrence in subclinical AF patients identified by SUNRISE?